Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

Hyloris Pharmaceuticals SA - Filing #3166306

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
11,282 EUR
7,145 EUR
Revenue
3,096 EUR
175,000 EUR
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
11,250 EUR
4,570 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
3,075 EUR
633,000 EUR
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
62,000 EUR
69,397 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.